Personal HealthAARP released a report today that finds that prices of widely used brand name prescription drugs skyrocketed last year – “skyrocketed” meaning climbed more than eight percent (8%) even while general inflation remained negative. The New York Times covered the findings here. The report – called Rx Price Watch – is the first of its kind, looking at the retail price of drugs – that is, the amount that is actually charged to consumers (and/or insurers). The findings of this …